OLIGO 2017 OXFORD

Oxford Symposia - 3rd Annual

OLIGO 2017 OXFORD:

Antisense & Therapeutic Nucleic Acids

10 April 2017, St Hilda's College, Oxford, UK

Twitter: @LPMHealthcare, #OligoOx17

Welcome to OLIGO 2017 Oxford

View Agenda

We are delighted to announce our third Oxford Symposium on antisense and therapeutic oligonucleotides.

The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics.

The symposium agenda is currently in progress and we welcome proposals for oral and poster presentation on THERAPEUTIC APPLICATIONS AND DELIVERY STRATEGIES of synthetic oligonucleotides, including:

>Antisense, catalytic oligonucloetides, aptamers
>Chemical modifications
>In vitro/in vivo applications
>Delivery strategies
>New technologies

We particularly encourage final year doctoral students and early/mid career postdoctoral researchers/junior group leaders to submit oral abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities. Please contact us on OLIGOMER@LPMHealthcare.com, with your presentation theme, or if you have any questions.

The Symposium will be co-hosted with our 4th annual aptamer symposium and exhibition, Aptamers 2017 (11-12 April 2017).